Cargando…
Graphene-based phenformin carriers for cancer cell treatment: a comparative study between oxidized and pegylated pristine graphene in human cells and zebrafish
Graphene is an attractive choice for the development of an effective drug carrier in cancer treatment due to its high adsorption area and pH-responsive drug affinity. In combination with the highly potent metabolic drug phenformin, increased doses could be efficiently delivered to cancer cells. This...
Autores principales: | Alhourani, Abdelnour, Førde, Jan-Lukas, Nasrollahzadeh, Mojdeh, Eichacker, Lutz Andreas, Herfindal, Lars, Hagland, Hanne Røland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417205/ https://www.ncbi.nlm.nih.gov/pubmed/36134366 http://dx.doi.org/10.1039/d1na00778e |
Ejemplares similares
-
Improved pH-Responsive Release of Phenformin from
Low-Defect Graphene Compared to Graphene Oxide
por: Alhourani, Abdelnour, et al.
Publicado: (2021) -
Functionalization of pristine graphene for the synthesis of covalent graphene–polyaniline nanocomposite
por: Park, Jaehyeung, et al.
Publicado: (2020) -
Applications of Pristine and Functionalized Carbon Nanotubes, Graphene, and Graphene Nanoribbons in Biomedicine
por: Burdanova, Maria G., et al.
Publicado: (2021) -
Large and pristine films of reduced graphene oxide
por: Ahn, Sung Il, et al.
Publicado: (2015) -
Equibiaxial Strained Oxygen Adsorption on Pristine Graphene, Nitrogen/Boron Doped Graphene, and Defected Graphene
por: Qu, Li-Hua, et al.
Publicado: (2020)